AbbVie (ABBV) Plans Pipeline Update at R&D Day Event; Includes IMBRUVICA, ABT-484 Data
Tweet Send to a Friend
At an R&D Day meeting today for the investment community, AbbVie (NYSE: ABBV) will present an overview of its innovative ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


